In Conversation

“ Pius Hornstein, MSc, PhD, country chair Sanofi Brazil and general manager Pharma, shares his positive outlook on the Brazilian pharma market over the next few years… ”
“ "Our vision is to integrate the top 52 companies in Brazil within the next five years and to double our operating income in the meantime." ”
“ "As ABIQUIFI, we are now working closely with the government and regulatory authorities to change the country’s paradigm in this regard and – for example -… ”
“ "Despite the difficulties associated with bringing new products to the market in Brazil, we have successfully launched six new products these years." ”
“ "As a very focused and segmented company, we need to ensure we leave enough time between each product launch to consolidate the latter’s market share, before… ”
“ "We are not only focused on financial results but we aim to achieve results while respecting each region and the local community, which is really fantastic." ”
“ "The challenge we are facing is that Brazil still lacks a strong international reputation in this area so we still need to prove and promote our… ”
“ "Orygen is an exciting hybrid between a commercial venture and an entrepreneurial, biotech start-up." ”
“ “Working in technology had quickly made me realize that my scientific vocation could find challenging objectives in industry too.” ”
“ "The biotech industry is very important for the innovation-oriented development of Brazil, our country should definitely allocate more resources to the dawn of this sector." ”
“ "The incorporation and exclusion of technologies in SUS is based on the presence of scientific evidence demonstrating that the technology is at least as effective and… ”
“ "Our overarching objective is to be recognized as the best company in our area and a frontrunner when it comes to the quality of our processes." ”
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here